CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: sulfamethoxazole
Accession: CHEBI:9332
browse the term
Definition: An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Synonyms: exact_synonym: 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
related_synonym: 3-(p-Aminophenylsulfonamido)-5-methylisoxazole; 3-Sulfanilamido-5-methylisoxazole; 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide; Formula=C10H11N3O3S; Gantanol (TN); InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13); InChIKey=JLKIGFTWXXRPMT-UHFFFAOYSA-N; SMILES=C=1(C=CC(=CC1)N)S(NC=2C=C(ON2)C)(=O)=O; SMX; sulphamethoxazole
alt_id: CHEBI:102247
xref: CAS:723-46-6; DrugBank:DB01015; Drug_Central:2514; Gmelin:226453; HMDB:HMDB0015150; KEGG:C07315; KEGG:D00447; LINCS:LSM-5422
xref_mesh: MESH:D013420
xref: PMID:10843725; PMID:10891117; PMID:10969989; PMID:11350866; PMID:11431418; PMID:12019187; PMID:15497867; PMID:15588915; PMID:15967282; PMID:15984773; PMID:17095123; PMID:17110110; PMID:17158933; PMID:17311370; PMID:17442935; PMID:17573190; PMID:18334600; PMID:18958736; PMID:19436870; PMID:20564608; PMID:22534821; PMID:226453; PMID:23611245; PMID:23649399; PMID:23742687; PMID:25851465; PMID:313909; PMID:3906132; PMID:6864729; PMID:7486915; PMID:7490723; PMID:7534104; PMID:7602118; PMID:7731020; PMID:7798534; PMID:8208693; PMID:8632413; Reaxys:226453; Wikipedia:Sulfamethoxazole
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity multiple interactions
ISO
Sulfamethoxazole results in decreased activity of ABCB11 protein Sulfamethoxazole inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD
PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Acan
aggrecan
decreases expression
EXP
Sulfamethoxazole results in decreased expression of ACAN mRNA
CTD
PMID:26107568
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
G
Alb
albumin
multiple interactions
ISO
Sulfamethoxazole metabolite binds to and results in increased metabolism of ALB protein
CTD
PMID:19358516
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Col2a1
collagen type II alpha 1 chain
decreases expression
EXP
Sulfamethoxazole results in decreased expression of COL2A1 mRNA
CTD
PMID:26107568
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
EXP
[SOD2 co-treated with CYP3A4] affects the susceptibility to Sulfamethoxazole
CTD
PMID:19501153
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Sulfamethoxazole metabolite binds to and results in increased metabolism of GSTP1 protein
CTD
PMID:19358516
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Ifng
interferon gamma
increases secretion
ISO
Sulfamethoxazole analog results in increased secretion of IFNG protein
CTD
PMID:15588915
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il5
interleukin 5
increases secretion
ISO
Sulfamethoxazole analog results in increased secretion of IL5 protein
CTD
PMID:15588915
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Mir155
microRNA 155
increases expression
ISO
Sulfamethoxazole results in increased expression of MIR155 mRNA
CTD
PMID:29644860
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir18a
microRNA 18a
increases expression
ISO
Sulfamethoxazole results in increased expression of MIR18A mRNA
CTD
PMID:29644860
NCBI chr15:92,180,765...92,180,860
Ensembl chr15:92,180,765...92,180,860
G
Mir21
microRNA 21
increases expression
ISO
Sulfamethoxazole results in increased expression of MIR21 mRNA
CTD
PMID:29644860
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mpo
myeloperoxidase
multiple interactions
ISO
[[MPO protein co-treated with Hydrogen Peroxide] results in increased oxidation of Sulfamethoxazole] which results in increased chemical synthesis of 4-nitrososulfamethoxazole; [MPO protein co-treated with Hydrogen Peroxide] results in increased oxidation of Sulfamethoxazole
CTD
PMID:25531135
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nat2
N-acetyltransferase 2
increases metabolic processing
ISO
NAT2 protein results in increased metabolism of Sulfamethoxazole
CTD
PMID:16847467
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Phyh
phytanoyl-CoA 2-hydroxylase
decreases expression
ISO
Sulfamethoxazole results in decreased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
G
Pir
pirin
increases expression
ISO
Sulfamethoxazole results in increased expression of PIR mRNA
CTD
PMID:22609641
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
affects expression
ISO
Sulfamethoxazole affects the expression of HLA-G mRNA
CTD
PMID:25811541
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Sod2
superoxide dismutase 2
multiple interactions
EXP
[SOD2 co-treated with CYP3A4] affects the susceptibility to Sulfamethoxazole
CTD
PMID:19501153
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sox9
SRY-box transcription factor 9
decreases expression
EXP
Sulfamethoxazole results in decreased expression of SOX9 mRNA
CTD
PMID:26107568
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Ins2
insulin 2
increases secretion
ISO
Trimethoprim, Sulfamethoxazole Drug Combination results in increased secretion of INS protein modified form
CTD
PMID:14714756
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
4-nitrososulfamethoxazole results in increased expression of AKR1B10 mRNA
CTD
PMID:28444390
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Hmgb1
high mobility group box 1
increases secretion
ISO
4-nitrososulfamethoxazole results in increased secretion of HMGB1 protein
CTD
PMID:28444390
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Ifng
interferon gamma
increases secretion
ISO
4-nitrososulfamethoxazole results in increased secretion of IFNG protein
CTD
PMID:22331489
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il13
interleukin 13
increases secretion
ISO
4-nitrososulfamethoxazole results in increased secretion of IL13 protein
CTD
PMID:22331489
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il1a
interleukin 1 alpha
increases secretion
ISO
4-nitrososulfamethoxazole results in increased secretion of IL1A protein
CTD
PMID:28444390
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases secretion
ISO
4-nitrososulfamethoxazole results in increased secretion of IL1B protein
CTD
PMID:28444390
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il5
interleukin 5
increases secretion
ISO
4-nitrososulfamethoxazole results in increased secretion of IL5 protein
CTD
PMID:22331489
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
increases secretion
ISO
4-nitrososulfamethoxazole results in increased secretion of IL6 protein
CTD
PMID:28444390
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mpo
myeloperoxidase
affects binding multiple interactions
ISO
4-nitrososulfamethoxazole binds to MPO protein [[MPO protein co-treated with Hydrogen Peroxide] results in increased oxidation of Sulfamethoxazole] which results in increased chemical synthesis of 4-nitrososulfamethoxazole
CTD
PMID:25531135
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
4-nitrososulfamethoxazole results in increased expression of NQO1 mRNA
CTD
PMID:28444390
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Srxn1
sulfiredoxin 1
increases expression
ISO
4-nitrososulfamethoxazole results in increased expression of SRXN1 mRNA
CTD
PMID:28444390
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Tnf
tumor necrosis factor
increases secretion
ISO
4-nitrososulfamethoxazole results in increased secretion of TNF protein
CTD
PMID:28444390
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
4-nitrososulfamethoxazole results in increased expression of TXNRD1 mRNA
CTD
PMID:28444390
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Cyb5b
cytochrome b5 type B
multiple interactions
ISO
[MTARC1 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine; [MTARC2 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine
CTD
PMID:25170804
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
G
Cyb5r3
cytochrome b5 reductase 3
multiple interactions
ISO
[MTARC1 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine; [MTARC2 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine
CTD
PMID:25170804
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
G
Mtarc1
mitochondrial amidoxime reducing component 1
multiple interactions
ISO
[MTARC1 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine
CTD
PMID:25170804
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
G
Mtarc2
mitochondrial amidoxime reducing component 2
multiple interactions
ISO
[MTARC2 protein co-treated with CYB5B protein co-treated with CYB5R3 protein co-treated with NAD] results in increased reduction of sulfamethoxazole hydroxylamine
CTD
PMID:25170804
NCBI chr13:96,362,810...96,397,284
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all